1-111780417-ATTT-ATTTT

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1

The NM_001378969.1(KCND3):​c.1372-104dupA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0234 in 1,170,170 control chromosomes in the GnomAD database, including 423 homozygotes. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.029 ( 81 hom., cov: 32)
Exomes 𝑓: 0.023 ( 342 hom. )

Consequence

KCND3
NM_001378969.1 intron

Scores

Not classified

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.72

Publications

2 publications found
Variant links:
Genes affected
KCND3 (HGNC:6239): (potassium voltage-gated channel subfamily D member 3) Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. Four sequence-related potassium channel genes - shaker, shaw, shab, and shal - have been identified in Drosophila, and each has been shown to have human homolog(s). This gene encodes a member of the potassium channel, voltage-gated, shal-related subfamily, members of which form voltage-activated A-type potassium ion channels and are prominent in the repolarization phase of the action potential. This member includes two isoforms with different sizes, which are encoded by alternatively spliced transcript variants of this gene. [provided by RefSeq, Jul 2008]
KCND3 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • spinocerebellar ataxia type 19/22
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, Ambry Genetics
  • Brugada syndrome 9
    Inheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
  • Brugada syndrome 1
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP6
Variant 1-111780417-A-AT is Benign according to our data. Variant chr1-111780417-A-AT is described in ClinVar as Likely_benign. ClinVar VariationId is 678725.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0613 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001378969.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCND3
NM_001378969.1
MANE Select
c.1372-104dupA
intron
N/ANP_001365898.1
KCND3
NM_004980.5
c.1372-104dupA
intron
N/ANP_004971.2
KCND3
NM_001378970.1
c.1372-104dupA
intron
N/ANP_001365899.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCND3
ENST00000302127.5
TSL:5 MANE Select
c.1372-104_1372-103insA
intron
N/AENSP00000306923.4
KCND3
ENST00000315987.6
TSL:1
c.1372-104_1372-103insA
intron
N/AENSP00000319591.2
KCND3
ENST00000369697.5
TSL:1
c.1372-104_1372-103insA
intron
N/AENSP00000358711.1

Frequencies

GnomAD3 genomes
AF:
0.0292
AC:
4431
AN:
151618
Hom.:
80
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0323
Gnomad AMI
AF:
0.0330
Gnomad AMR
AF:
0.0557
Gnomad ASJ
AF:
0.0110
Gnomad EAS
AF:
0.0666
Gnomad SAS
AF:
0.0446
Gnomad FIN
AF:
0.0221
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0195
Gnomad OTH
AF:
0.0279
GnomAD4 exome
AF:
0.0225
AC:
22937
AN:
1018434
Hom.:
342
AF XY:
0.0233
AC XY:
12094
AN XY:
517948
show subpopulations
African (AFR)
AF:
0.0295
AC:
698
AN:
23638
American (AMR)
AF:
0.0519
AC:
1768
AN:
34072
Ashkenazi Jewish (ASJ)
AF:
0.00902
AC:
204
AN:
22616
East Asian (EAS)
AF:
0.0610
AC:
2060
AN:
33744
South Asian (SAS)
AF:
0.0436
AC:
3084
AN:
70722
European-Finnish (FIN)
AF:
0.0174
AC:
840
AN:
48144
Middle Eastern (MID)
AF:
0.0209
AC:
91
AN:
4350
European-Non Finnish (NFE)
AF:
0.0176
AC:
12970
AN:
736262
Other (OTH)
AF:
0.0272
AC:
1222
AN:
44886
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
995
1991
2986
3982
4977
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
438
876
1314
1752
2190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0292
AC:
4434
AN:
151736
Hom.:
81
Cov.:
32
AF XY:
0.0320
AC XY:
2370
AN XY:
74152
show subpopulations
African (AFR)
AF:
0.0322
AC:
1335
AN:
41398
American (AMR)
AF:
0.0555
AC:
846
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.0110
AC:
38
AN:
3462
East Asian (EAS)
AF:
0.0672
AC:
346
AN:
5152
South Asian (SAS)
AF:
0.0446
AC:
214
AN:
4798
European-Finnish (FIN)
AF:
0.0221
AC:
233
AN:
10526
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0195
AC:
1326
AN:
67864
Other (OTH)
AF:
0.0276
AC:
58
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
209
419
628
838
1047
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00523
Hom.:
2
Bravo
AF:
0.0303

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 19, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72548727; hg19: chr1-112323039; API